CUAMC
China Universal Asset Management Company’s Cogent Biosciences COGT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $164K | Buy |
22,868
+32
| +0.1% | +$230 | 0.02% | 328 |
|
|
2025
Q1 | $137K | Sell |
22,836
-586
| -3% | -$3.51K | 0.01% | 340 |
|
|
2024
Q4 | $183K | Buy |
23,422
+2,371
| +11% | +$18.5K | 0.02% | 335 |
|
|
2024
Q3 | $227K | Buy |
21,051
+9,819
| +87% | +$106K | 0.03% | 291 |
|
|
2024
Q2 | $94.7K | Sell |
11,232
-8,718
| -44% | -$73.5K | 0.01% | 305 |
|
|
2024
Q1 | $134K | Buy |
19,950
+9,989
| +100% | +$67.1K | 0.02% | 342 |
|
|
2023
Q4 | $58.6K | Buy |
9,961
+7,772
| +355% | +$45.7K | 0.01% | 353 |
|
|
2023
Q3 | $21.3K | Buy |
2,189
+1,259
| +135% | +$12.3K | 0.01% | 293 |
|
|
2023
Q2 | $11K | Sell |
930
-17
| -2% | -$201 | ﹤0.01% | 311 |
|
|
2023
Q1 | $10.2K | Buy |
947
+237
| +33% | +$2.56K | ﹤0.01% | 291 |
|
|
2022
Q4 | $8.21K | Buy |
710
+95
| +15% | +$1.1K | ﹤0.01% | 246 |
|
|
2022
Q3 | $9K | Buy |
+615
| New | +$9K | ﹤0.01% | 213 |
|